All listed pharmaceutical companies have advanced on the stock market, but Grifols, whose shares have fallen by more than 12%, has weighed down the sector. The...
Eli Lilly & Co. makes second major pharmaceutical deal this year by paying cancer drug specialists Loxo Oncology $8 billion.